Headlands Research, a leading multinational network of clinical trial sites, announces the acquisition of Pharmasite Research, an established clinical trial site dedicated to research in mental illness and disorders of the central nervous system (CNS). Located outside Baltimore, Maryland, Pharmasite Research brings over 20 years of clinical research expertise in two of Headland Research’s core competencies: mental health and CNS. As Headlands Research continues to expand and bring clinical research to a more diverse, representative population, Pharmasite’s strategic location extends the site network’s reach in the Mid-Atlantic region. Headlands Research now includes 18 sites across the United States and Canada.
Read the full article: Headlands Research Acquires Clinical Trial Site Pharmasite Research, Enhancing Therapeutic Expertise in Key Competencies //
Source: https://www.prnewswire.com/news-releases/headlands-research-acquires-clinical-trial-site-pharmasite-research-enhancing-therapeutic-expertise-in-key-competencies-302075068.html